Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar;180(3):P1-P22.
doi: 10.1530/EJE-18-0609.

Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus

Aliya A Khan  1 , Christian A Koch  2 , Stan Van Uum  3 , Jean Patrice Baillargeon  4 , Jens Bollerslev  5 , Maria Luisa Brandi  6 , Claudio Marcocci  7 , Lars Rejnmark  8 , Rene Rizzoli  9 , M Zakarea Shrayyef  10 , Rajesh Thakker  11 , Bulent O Yildiz  12 , Bart Clarke  13
Affiliations
Review

Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus

Aliya A Khan et al. Eur J Endocrinol. 2019 Mar.

Abstract

Purpose: To provide practice recommendations for the diagnosis and management of hypoparathyroidism in adults.

Methods: Key questions pertaining to the diagnosis and management of hypoparathyroidism were addressed following a literature review. We searched PubMed, MEDLINE, EMBASE and Cochrane databases from January 2000 to March 2018 using keywords 'hypoparathyroidism, diagnosis, treatment, calcium, PTH, calcidiol, calcitriol, hydrochlorothiazide and pregnancy'. Only English language papers involving humans were included. We excluded letters, reviews and editorials. The quality of evidence was evaluated based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. These standards of care for hypoparathyroidism have been endorsed by the Canadian Society of Endocrinology and Metabolism.

Results: Hypoparathyroidism is a rare disease characterized by hypocalcemia, hyperphosphatemia and a low or inappropriately normal serum parathyroid hormone level (PTH). The majority of cases are post-surgical (75%) with nonsurgical causes accounting for the remaining 25% of cases. A careful review is required to determine the etiology of the hypoparathyroidism in individuals with nonsurgical disease. Hypoparathyroidism is associated with significant morbidity and poor quality of life. Treatment requires close monitoring as well as patient education. Conventional therapy with calcium supplements and active vitamin D analogs is effective in improving serum calcium as well as in controlling the symptoms of hypocalcemia. PTH replacement is of value in lowering the doses of calcium and active vitamin D analogs required and may be of value in lowering long-term complications of hypoparathyroidism. This manuscript addresses acute and chronic management of hypoparathyroidism in adults.

Main conclusions: Hypoparathyroidism requires careful evaluation and pharmacologic intervention in order to improve serum calcium and control the symptoms of hypocalcemia. Frequent laboratory monitoring of the biochemical profile and patient education is essential to achieving optimal control of serum calcium.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram.
See this image and copyright information in PMC

References

    1. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Flack-Ytter Y, Glasziou P, Debeer H. et al GRADE guidelines: 1. Introduction – GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011. 64 383–394. (10.1016/j.jclinepi.2010.04.026) - DOI - PubMed
    1. Shoback D. Clinical practice. Hypoparathyroidism. New England Journal of Medicine 2008. 359 391–403. (10.1056/NEJMcp0803050) - DOI - PubMed
    1. Bilezikian JP, Khan A, Potts JT, Brandi ML, Clarke BL, Shoback D, Juppner H, D’Amour P, Fox J, Rejnmark L. et al Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. Journal of Bone and Mineral Research 2011. 10 2317–2337. (10.1002/jbmr.483) - DOI - PMC - PubMed
    1. Shoback DM, Bilezikian JP, Costa AG, Dempster D, Dralle H, Khan AA, Bouillon R. Presentation of hypoparathyroidism: etiologies and clinical features. Journal of Clinical Endocrinology and Metabolism 2016. 101 2300–2312. (10.1210/jc.2015-3909) - DOI - PubMed
    1. Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, Shoback DM. Hypoparathyroidism. Nature Reviews Disease Primers 2017. 3 17055 (10.1038/nrdp.2017.55) - DOI - PubMed